4.2 Article

A Click Synthesis, Molecular Docking and Biological Evaluation of 1,2,3-triazoles-benzoxazepine hybrid as potential anticancer agents

Related references

Note: Only part of the references are listed.
Article Biochemistry & Molecular Biology

Discovery of new PKN2 inhibitory chemotypes via QSAR-guided selection of docking-based pharmacophores

Mahmoud A. Al-Sha'er et al.

Summary: Serine/threonine-protein kinase N2 (PKN2) plays important roles in cell cycle progression, migration, adhesion, and transcription activation signaling processes, as well as in cancer cell migration, invasion, and apoptosis. In this study, a QSAR-guided selection of docking-based pharmacophores approach was used to model PKN2 as a potential therapeutic target for cancer. Several pharmacophores were extracted from docked ligand poses and used to screen for new anti-PKN2 leads. Three promising compounds with low micromolar IC50 values were identified and showed cytotoxic properties against cancer cells in pharmacological assays.

MOLECULAR DIVERSITY (2023)

Article Biochemistry & Molecular Biology

Exploiting activity cliffs for building pharmacophore models and comparison with other pharmacophore generation methods: sphingosine kinase 1 as case study

Lubabah A. Mousa et al.

Summary: This study introduces a new method for extracting valid binding pharmacophores using activity cliffs pairs and applying genetic algorithm/machine learning for selection. The new approach showed comparable accuracies to established methods in the case study of Sphingosine kinase 1.

JOURNAL OF COMPUTER-AIDED MOLECULAR DESIGN (2022)

Article Biochemistry & Molecular Biology

Design, Synthesis, and Biological Evaluation of Novel MAO-A Inhibitors Targeting Lung Cancer

Sanaa Bardaweel et al.

Summary: Lung cancer, a common cause of cancer-related deaths, can be inhibited by novel MAO-A inhibitors that suppress the production of reactive oxygen species (ROS) and hinder the growth of lung cancer cells. These inhibitors could potentially serve as new targets for chemotherapy.

MOLECULES (2022)

Article Chemistry, Multidisciplinary

Discovery of new Cdc2-like kinase 4 (CLK4) inhibitors via pharmacophore exploration combined with flexible docking-based ligand/receptor contact fingerprints and machine learning

Mai Fayiz Al-Tawil et al.

Summary: This study investigated the pharmacophoric and binding requirements for potent CLK4 antagonists using ligand-based pharmacophore exploration, docking, physicochemical descriptors, and machine learning analyses. A predictive model was generated using the genetic function algorithm with support vector regression, and three potential CLK4 antagonists were discovered in the screening process.

RSC ADVANCES (2022)

Article Chemistry, Multidisciplinary

Design, Synthesis, Molecular Modeling, Anticancer Studies, and Density Functional Theory Calculations of 4-(1,2,4-Triazol-3-ylsulfanylmethyl)-1,2,3-triazole Derivatives

Adeeb Al Sheikh Ali et al.

Summary: New conjugates of 1,2,3-triazoles linked to 1,2,4-triazoles were synthesized and screened for anticancer activity against various cancer cell lines, showing promising results. The compounds with the highest potency demonstrated superior interactions with the target protein and exhibited significant anticancer activity. DFT calculations were performed to confirm the results of molecular docking and experimental findings.

ACS OMEGA (2021)

Article Chemistry, Medicinal

Inhibition of protein kinases by proton pump inhibitors: computational screening and in vitro evaluation

Husam Nassar et al.

Summary: Proton pump inhibitors (PPIs) were identified as potential kinase inhibitors, with lansoprazole and rabeprazole showing inhibitory effects on CaMKII δ, FLT3, and TYK2.

MEDICINAL CHEMISTRY RESEARCH (2021)

Article Chemistry, Medicinal

Structure-based discovery of new polo-like kinase 1 (PLK1) inhibitors as potential anticancer agents via docking-based comparative intermolecular contacts analysis (dbCICA)

Saja Adel Alassaf et al.

Summary: In this study, a computational workflow named dbCICA was used to discover new PLK1 inhibitors, resulting in the identification of two promising hits with IC50 values of 6.30 and 19.1 mu M for compounds 89 and 103, respectively.

MEDICINAL CHEMISTRY RESEARCH (2021)

Article Chemistry, Medicinal

Synthesis and anti-proliferative activity of a novel 1,2,3-triazole tethered chalcone acetamide derivatives

Satheeshvarma Vanaparthi et al.

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2020)

Article Biochemistry & Molecular Biology

Efflux mechanism and pathway of verapamil pumping by human P-glycoprotein

Lijie Wang et al.

ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS (2020)

Review Chemistry, Medicinal

Comprehensive review on the anti-bacterial activity of 1,2,3-triazole hybrids

Bo Zhang

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2019)

Review Chemistry, Medicinal

Current advances of triazole alcohols derived from fluconazole: Design, in vitro and in silico studies

Saeed Emami et al.

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2019)

Review Chemistry, Medicinal

Tetrazole hybrids with potential anticancer activity

Jingyu Zhang et al.

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2019)

Article Biochemical Research Methods

Discovery of novel Flt3 inhibitory chemotypes through extensive ligand-based and new structure-based pharmacophore modelling methods

Reem Fawaz Abutayeh et al.

JOURNAL OF MOLECULAR GRAPHICS & MODELLING (2019)

Article Chemistry, Medicinal

QSAR-guided pharmacophore modeling and subsequent virtual screening identify novel TYK2 inhibitor

Elham Y. Al-Barghouthy et al.

MEDICINAL CHEMISTRY RESEARCH (2019)

Review Chemistry, Medicinal

The potential role of tubeimosides in cancer prevention and treatment

Md Sodrul Islam et al.

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2019)

Review Oncology

Recent Advancements in 1,4-Disubstituted 1H-1,2,3-Triazoles as Potential Anticancer Agents

Kashmiri Lal et al.

ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY (2018)

Article Chemistry, Medicinal

Dihydropyrimidinone/1,2,3-triazole hybrid molecules: Synthesis and anti-varicella-zoster virus (VZV) evaluation

Hanane Kaoukabi et al.

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2018)

Review Chemistry, Medicinal

A review on diverse heterocyclic compounds as the privileged scaffolds in antimalarial drug discovery

Piyush N. Kalaria et al.

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2018)

Review Chemistry, Medicinal

4-Quinolone hybrids and their antibacterial activities

Yuan-Qiang Hu et al.

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2017)

Article Chemistry, Medicinal

Green synthesis and anticancer potential of chalcone linked-1,2,3-triazoles

Pinki Yadav et al.

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2017)

Article Biochemistry & Molecular Biology

Discovery of new selective cytotoxic agents against Bcl-2 expressing cancer cells using ligand-based modeling

Nour H. Aboalhaija et al.

CHEMICO-BIOLOGICAL INTERACTIONS (2016)

Review Chemistry, Medicinal

Hybrid molecules: The privileged scaffolds for various pharmaceuticals

Shaveta et al.

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2016)

Article Chemistry, Medicinal

Computer-aided discovery of new FGFR-1 inhibitors followed by in vitro validation

Shada J. Alabed et al.

FUTURE MEDICINAL CHEMISTRY (2016)

Article Biochemistry & Molecular Biology

6,7-Dihydrobenzo[f]benzo[4,5]imidazo[1,2-d][1,4]oxazepine derivatives as selective inhibitors of PI3Kα

Yong Yin et al.

BIOORGANIC & MEDICINAL CHEMISTRY (2015)

Review Biochemistry & Molecular Biology

Triazole: A Promising Antitubercular Agent

Rangappa S. Keri et al.

CHEMICAL BIOLOGY & DRUG DESIGN (2015)

Article Chemistry, Medicinal

Spirooxindole-derived morpholine-fused-1,2,3-triazoles: Design, synthesis, cytotoxicity and apoptosis inducing studies

Kishna Ram Senwar et al.

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2015)

Article Chemistry, Medicinal

Benzimidazole-1,2,3-triazole Hybrid Molecules: Synthesis and Evaluation for Antibacterial/Antifungal Activity

Abdelaaziz Ouahrouch et al.

ARCHIV DER PHARMAZIE (2014)

Article Biochemistry & Molecular Biology

Elaborate ligand-based modeling reveal new submicromolar Rho kinase inhibitors

Rand Shahin et al.

JOURNAL OF COMPUTER-AIDED MOLECULAR DESIGN (2012)

Article Chemistry, Medicinal

Synthesis and Antimicrobial Activity of 1,2,3-Triazoles Containing Quinoline Moiety

V. Sumangala et al.

ARCHIVES OF PHARMACAL RESEARCH (2010)

Article Chemistry, Medicinal

Elaborate Ligand-Based Modeling Reveals New Nanomolar Heat Shock Protein 90α Inhibitors

Mahmoud A. Al-Sha'er et al.

JOURNAL OF CHEMICAL INFORMATION AND MODELING (2010)

Article Chemistry, Medicinal

Clubbed [1,2,3] triazoles by fluorine benzimidazole: A novel approach to H37Rv inhibitors as a potential treatment for tuberculosis

Charansingh Gill et al.

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2008)

Review Pharmacology & Pharmacy

The challenge of selecting protein kinase assays for lead discovery optimization

Haiching Ma et al.

EXPERT OPINION ON DRUG DISCOVERY (2008)

Article Chemistry, Medicinal

Contribution of conformer focusing to the uncertainty in predicting free energies for protein-ligand binding

Julian Tirado-Rives et al.

JOURNAL OF MEDICINAL CHEMISTRY (2006)

Article Chemistry, Multidisciplinary

Detailed analysis of grid-based molecular docking: A case study of CDOCKER - A CHARMm-based MD docking algorithm

GS Wu et al.

JOURNAL OF COMPUTATIONAL CHEMISTRY (2003)